verified peptides tirzepatide Premium Peptide | Dual Agonist Tirzepatide (GLP-2) Research Peptide |

Most studies focus on diabetes or weight loss, so its unclear if these drugs could trigger or worsen HS symptoms

They're part of a class of medications called GLP-1 agonists, including semaglutide (sold as Ozempic and Wegovy), which have transformed obesity treatment in recent years

The Phase 2 trial published in the New England Journal of Medicine in 2023 reported up to 24% average weight loss at 48 weeks at the highest dose the largest number ever recorded for an obesity drug

Effectiveness of Semaglutide for Weight Loss Clinical Trial Results There have been several large-scale clinical studies demonstrating the effectiveness of semaglutide for weight loss